Information Collection: 10 CFR Part 35, “Medical Use of Byproduct Material”, 8959-8960 [2017-02074]
Download as PDF
Federal Register / Vol. 82, No. 20 / Wednesday, February 1, 2017 / Notices
FOR FURTHER INFORMATION CONTACT:
NUCLEAR REGULATORY
COMMISSION
[Docket No. 50–333; NRC–2016–0059]
Entergy Nuclear Operations, Inc.;
James A. FitzPatrick Nuclear Power
Plant
Nuclear Regulatory
Commission.
ACTION: License amendment application;
withdrawal by applicant.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) has granted the
request of Entergy Nuclear Operations,
Inc. (Entergy, the licensee), to withdraw
its application dated February 4, 2016,
for a proposed amendment to Facility
Operating License No. DPR–59. The
proposed amendment request would
have revised the James A. FitzPatrick
Nuclear Power Plant (JAF) Emergency
Plan to reduce the Emergency Response
Organization (ERO) positions that the
licensee considers unnecessary to
effectively respond to credible accidents
following permanent defueling.
ADDRESSES: Please refer to Docket ID
NRC–2016–0059 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2016–0059. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced (if it is available in
ADAMS) is provided the first time that
it is mentioned in this document.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:23 Jan 31, 2017
Jkt 241001
James Kim, Office of Nuclear Reactor
Regulation, U.S. Nuclear Regulatory
Commission, Washington DC 20555–
0001; telephone: 301–415–4125; email:
James.Kim@nrc.gov.
SUPPLEMENTARY INFORMATION: The NRC
has granted the request of Entergy to
withdraw its application dated February
4, 2016 (ADAMS Accession No.
ML16043A424), for a proposed
amendment to Facility Operating
License No. DPR–59 for JAF, located in
Oswego County, New York. The
proposed amendment request would
have revised the JAF Emergency Plan to
reduce the ERO positions that the
licensee considers unnecessary to
effectively respond to credible accidents
following permanent defueling.
The Commission has previously
issued a proposed finding that the
amendment involves no significant
hazards consideration published in the
Federal Register on March 29, 2016 (81
FR 17504). However, by letter dated
January 13, 2017 (ADAMS Accession
No. ML17015A000), the licensee
requested to withdraw the proposed
amendment.
Dated at Rockville, Maryland, this 25th day
of January 2017.
For the Nuclear Regulatory Commission.
James Kim,
Project Manager, Special Projects and Process
Branch, Division of Operating Reactor
Licensing, Office of Nuclear Reactor
Regulation.
[FR Doc. 2017–02130 Filed 1–31–17; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2017–0013]
Information Collection: 10 CFR Part 35,
‘‘Medical Use of Byproduct Material’’
Nuclear Regulatory
Commission.
ACTION: Renewal of existing information
collection; request for comment.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) invites public
comment on the renewal of Office of
Management and Budget (OMB)
approval for an existing collection of
information. The information collection
is entitled, 10 CFR part 35, ‘‘Medical
Use of Byproduct Material.’’
DATES: Submit comments by April 3,
2017. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
8959
You may submit comments
by any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2017–0013. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: David Cullison,
Office of the Chief Information Officer,
Mail Stop: T–5 F53, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
David Cullison, Office of the Chief
Information Officer, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
2084; email: INFOCOLLECTS.Resource@
nrc.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–20170013 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2017–0013.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
supporting statement is available in
ADAMS under Accession No.
ML16333A028.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
E:\FR\FM\01FEN1.SGM
01FEN1
8960
Federal Register / Vol. 82, No. 20 / Wednesday, February 1, 2017 / Notices
instructions may be obtained without
charge by contacting NRC’s Clearance
Officer, David Cullison, Office of the
Chief Information Officer, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
2084; email: INFOCOLLECTS.Resource@
nrc.gov.
sradovich on DSK3GMQ082PROD with NOTICES
B. Submitting Comments
Please include Docket ID NRC–2017–
0013 in the subject line of your
comment submission, in order to ensure
that the NRC is able to make your
comment submission available to the
public in this docket.
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
want to be publicly disclosed in your
comment submission. The NRC will
post all comment submissions at https://
www.regulations.gov as well as enter the
comment submissions into ADAMS,
and the NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Background
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting
public comment on its intention to
request the OMB’s approval for the
information collection summarized
below.
1. The title of the information
collection: 10 CFR part 35, ‘‘Medical
Use of Byproduct Material.’’
2. OMB approval number: 3150–0010
3. Type of submission: Extension
4. The form number, if applicable:
N/A
5. How often the collection is required
or requested: Reports of medical events,
doses to an embryo/fetus or nursing
child, or leaking source are reportable
on occurrence. A specialty board
certifying entity desiring to be
recognized by the NRC must submit a
one-time request for recognition and
infrequently revise the information.
6. Who will be required or asked to
respond: Physicians and medical
institutions holding an NRC license
authorizing the administration of
VerDate Sep<11>2014
16:23 Jan 31, 2017
Jkt 241001
byproduct material or radiation from
this material to humans for medical use.
A specialty board certification entity
desiring to have its certifying process
and board certificate recognized by
NRC.
7. The estimated number of annual
responses: 276,359 ((NRC: 36,313 + 962
recordkeepers = 37,275) + (Agreement
States: 232,925 + 6,157 recordkeepers +
2 specialty certification entity =
239,084)).
8. The estimated number of annual
respondents: 7,121(NRC: 962 +
Agreement states 6,157+ 2 specialty
certification entities).
9. The estimated number of hours
needed annually to comply with the
information collection requirement or
request: 1,073,224 hours (NRC Licensees
145,195 hrs + Agreement States 928,027
hrs + specialty certifying entities 2 hrs).
10. Abstract: 10 CFR part 35,
‘‘Medical Use of Byproduct Material,’’
contains NRC’s requirements and
provisions for the medical use of
byproduct material and for issuance of
specific licenses authorizing the
medical use of this material. These
requirements and provisions provide for
the radiation safety of workers, the
general public, patients, and human
research subjects. Part 35 contains
mandatory requirements that apply to
NRC licensees authorized to administer
byproduct material or radiation
therefrom to humans for medical use.
These requirements also provide
voluntary provisions for specialty
boards to apply to have their
certification processes recognized by the
NRC so that their board certified
individuals can use the certifications as
proof of training and experience.
III. Specific Requests for Comments
The NRC is seeking comments that
address the following questions:
1. Is the proposed collection of
information necessary for the NRC to
properly perform its functions? Does the
information have practical utility?
2. Is the estimate of the burden of the
information collection accurate?
3. Is there a way to enhance the
quality, utility, and clarity of the
information to be collected?
4. How can the burden of the
information collection on respondents
be minimized, including the use of
automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 26th day
of January 2017.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer.
[FR Doc. 2017–02074 Filed 1–31–17; 8:45 am]
BILLING CODE 7590–01–P
POSTAL SERVICE
Temporary Emergency Committee of
the Board of Governors; Sunshine Act
Meeting
Wednesday, February
8, 2017, at 8:00 a.m.
PLACE: Washington, DC.
STATUS: Closed.
MATTERS TO BE CONSIDERED:
DATES AND TIMES:
Wednesday, February 8, 2017, at 8:00
a.m.
1. Strategic Issues.
2. Financial Matters.
3. Personnel Matters and
Compensation Issues.
4. Executive Session—Discussion of
prior agenda items and Temporary
Emergency Committee governance.
GENERAL COUNSEL CERTIFICATION: The
General Counsel of the United States
Postal Service has certified that the
meeting may be closed under the
Government in the Sunshine Act.
CONTACT PERSON FOR MORE INFORMATION:
Julie S. Moore, Secretary of the Board,
U.S. Postal Service, 475 L’Enfant Plaza
SW., Washington, DC 20260–1000.
Telephone: (202) 268–4800.
Julie S. Moore,
Secretary.
[FR Doc. 2017–02256 Filed 1–30–17; 4:15 pm]
BILLING CODE 7710–12–P
PRESIDIO TRUST
Notice of Public Meeting of Presidio
Institute Advisory Council
The Presidio Trust.
Notice of public meeting of
Presidio Institute Advisory Council.
AGENCY:
ACTION:
Pursuant to the Federal
Advisory Committee Act, as amended,
notice is hereby given that a public
meeting of the Presidio Institute
Advisory Council (Council) will be held
from 1:00 p.m. to 3:00 p.m. on Tuesday,
March 7, 2017. The meeting is open to
the public, and oral public comment
will be received at the meeting. The
Council was formed to advise the CEO
of the Presidio Trust (Trust) on matters
pertaining to the rehabilitation and
reuse of Fort Winfield Scott as a new
national center focused on service and
leadership development.
SUMMARY:
E:\FR\FM\01FEN1.SGM
01FEN1
Agencies
[Federal Register Volume 82, Number 20 (Wednesday, February 1, 2017)]
[Notices]
[Pages 8959-8960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02074]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2017-0013]
Information Collection: 10 CFR Part 35, ``Medical Use of
Byproduct Material''
AGENCY: Nuclear Regulatory Commission.
ACTION: Renewal of existing information collection; request for
comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on the renewal of Office of Management and Budget (OMB)
approval for an existing collection of information. The information
collection is entitled, 10 CFR part 35, ``Medical Use of Byproduct
Material.''
DATES: Submit comments by April 3, 2017. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2017-0013. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Mail comments to: David Cullison, Office of the Chief
Information Officer, Mail Stop: T-5 F53, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
INFOCOLLECTS.Resource@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2017- 0013 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2017-0013.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The
supporting statement is available in ADAMS under Accession No.
ML16333A028.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
NRC's Clearance Officer: A copy of the collection of
information and related
[[Page 8960]]
instructions may be obtained without charge by contacting NRC's
Clearance Officer, David Cullison, Office of the Chief Information
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001;
telephone: 301-415-2084; email: INFOCOLLECTS.Resource@nrc.gov.
B. Submitting Comments
Please include Docket ID NRC-2017-0013 in the subject line of your
comment submission, in order to ensure that the NRC is able to make
your comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information in comment submissions that you do not want to be publicly
disclosed in your comment submission. The NRC will post all comment
submissions at https://www.regulations.gov as well as enter the comment
submissions into ADAMS, and the NRC does not routinely edit comment
submissions to remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
1. The title of the information collection: 10 CFR part 35,
``Medical Use of Byproduct Material.''
2. OMB approval number: 3150-0010
3. Type of submission: Extension
4. The form number, if applicable: N/A
5. How often the collection is required or requested: Reports of
medical events, doses to an embryo/fetus or nursing child, or leaking
source are reportable on occurrence. A specialty board certifying
entity desiring to be recognized by the NRC must submit a one-time
request for recognition and infrequently revise the information.
6. Who will be required or asked to respond: Physicians and medical
institutions holding an NRC license authorizing the administration of
byproduct material or radiation from this material to humans for
medical use. A specialty board certification entity desiring to have
its certifying process and board certificate recognized by NRC.
7. The estimated number of annual responses: 276,359 ((NRC: 36,313
+ 962 recordkeepers = 37,275) + (Agreement States: 232,925 + 6,157
recordkeepers + 2 specialty certification entity = 239,084)).
8. The estimated number of annual respondents: 7,121(NRC: 962 +
Agreement states 6,157+ 2 specialty certification entities).
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1,073,224 hours (NRC
Licensees 145,195 hrs + Agreement States 928,027 hrs + specialty
certifying entities 2 hrs).
10. Abstract: 10 CFR part 35, ``Medical Use of Byproduct
Material,'' contains NRC's requirements and provisions for the medical
use of byproduct material and for issuance of specific licenses
authorizing the medical use of this material. These requirements and
provisions provide for the radiation safety of workers, the general
public, patients, and human research subjects. Part 35 contains
mandatory requirements that apply to NRC licensees authorized to
administer byproduct material or radiation therefrom to humans for
medical use. These requirements also provide voluntary provisions for
specialty boards to apply to have their certification processes
recognized by the NRC so that their board certified individuals can use
the certifications as proof of training and experience.
III. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 26th day of January 2017.
For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer.
[FR Doc. 2017-02074 Filed 1-31-17; 8:45 am]
BILLING CODE 7590-01-P